1 - 10 out of 39Page size: 10
  1. 2024

  2. Acute blood loss in mice forces differentiation of both CD45-positive and CD45-negative erythroid cells and leads to a decreased CCL3 chemokine production by bone marrow erythroid cells

    Nazarov, K., Perik-Zavodskii, R., Perik-Zavodskaia, O., Alrhmoun, S., Volynets, M., Shevchenko, J. & Sennikov, S., Sept 2024, In: PLoS ONE. 19, 9, 18 p., e0309455.

    Research output: Contribution to journal › Article › peer-review

  3. NY-ESO-1 antigen: A promising frontier in cancer immunotherapy.

    Alsalloum, A., Shevchenko, J. A. & Sennikov, S., Sept 2024, In: Clinical and translational medicine. 14, 9, p. e70020

    Research output: Contribution to journal › Article › peer-review

  4. A subpopulation of human bone marrow erythroid cells displays a myeloid gene expression signature similar to that of classic monocytes

    Perik-Zavodskii, R., Perik-Zavodskaia, O., Shevchenko, J., Volynets, M., Alrhmoun, S., Nazarov, K., Denisova, V. & Sennikov, S., Jul 2024, In: PLoS ONE. 19, 7 July, e0305816.

    Research output: Contribution to journal › Article › peer-review

  5. 2023

  6. Phenotypic Alterations in Erythroid Nucleated Cells of Spleen and Bone Marrow in Acute Hypoxia

    Nazarov, K., Perik-Zavodskii, R., Perik-Zavodskaia, O., Alrhmoun, S., Volynets, M., Shevchenko, J. & Sennikov, S., Dec 2023, In: Cells. 12, 24, 2810.

    Research output: Contribution to journal › Article › peer-review

  7. TCR-Engineered Lymphocytes Targeting NY-ESO-1: In Vitro Assessment of Cytotoxicity against Tumors

    Alsalloum, A., Alrhmoun, S., Shevchenko, J., Fisher, M., Philippova, J., Perik-Zavodskii, R., Perik-Zavodskaia, O., Lopatnikova, J., Kurilin, V., Volynets, M., Akahori, Y., Shiku, H., Silkov, A. & Sennikov, S., 16 Oct 2023, In: Biomedicines. 11, 10, 2805.

    Research output: Contribution to journal › Article › peer-review

  8. Exploring TCR-like CAR-Engineered Lymphocyte Cytotoxicity against MAGE-A4

    Alsalloum, A., Shevchenko, J., Fisher, M., Philippova, J., Perik-Zavodskii, R., Perik-Zavodskaia, O., Alrhmoun, S., Lopatnikova, J., Vasily, K., Volynets, M., Zavjalov, E., Solovjeva, O., Akahori, Y., Shiku, H., Silkov, A. & Sennikov, S., 13 Oct 2023, In: International Journal of Molecular Sciences. 24, 20, 15134.

    Research output: Contribution to journal › Article › peer-review

  9. Parameters of TNF receptor co-expression in allergic and autoimmune processes: Differences and diagnostic significance

    Alshevskaya, A., Zhukova, J., Lopatnikova, J., Shkaruba, N., Chumasova, O., Sizikov, A., Demina, D., Nepomniashchikh, V., Gladkikh, V. & Sennikov, S., Sept 2023, In: Journal of immunological methods. 520, 7 p., 113525.

    Research output: Contribution to journal › Article › peer-review

  10. The Melanoma-Associated Antigen Family A (MAGE-A): A Promising Target for Cancer Immunotherapy?

    Alsalloum, A., Shevchenko, J. A. & Sennikov, S., 15 Mar 2023, In: Cancers. 15, 6, 1779.

    Research output: Contribution to journal › Review article › peer-review

  11. Development of experimental mouse xenograft models of human tumors for preclinical in vivo studies of product for cellular immunotherapy

    Lopatnikova, J. A., Shevchenko, J. A., Filippova, J. G., Fisher, M. S., Obleukhova, I. A., Zavjalov, E. L., Solovjeva, O. I., Razumov, I. A., Akahori, Y., Shiku, H. & Sennikov, S. V., 2023, In: Immunologiya. 44, 6, p. 709-720 12 p.

    Research output: Contribution to journal › Article › peer-review

  12. Investigation of TNF receptor coexpression parameters as potential biomarkers of effective hospital therapy with rituximab in patients with rheumatoid arthritis

    Alshevskaya, A. A., Lopatnikova, J. A., Zhukova, J. V., Kireev, F. D., Gladkikh, V. S., Shkaruba, N. S., Chumasova, O. A., Sizikov, A. E. & Sennikov, S. V., 2023, In: Immunologiya. 44, 4, p. 429-443 15 p.

    Research output: Contribution to journal › Article › peer-review

Previous 1 2 3 4 Next

ID: 16345732